| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.CELLSIG.2004.01.008 |
| P698 | PubMed publication ID | 15157674 |
| P50 | author | Michael Simons | Q39375925 |
| P2093 | author name string | Chohreh Partovian | |
| P2860 | cites work | Regulation of endothelium-derived nitric oxide production by the protein kinase Akt | Q22010149 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| phosphorylation | Q242736 | ||
| P304 | page(s) | 951-957 | |
| P577 | publication date | 2004-08-01 | |
| P1433 | published in | Cellular Signalling | Q1524097 |
| P1476 | title | Regulation of protein kinase B/Akt activity and Ser473 phosphorylation by protein kinase Calpha in endothelial cells | |
| P478 | volume | 16 |
| Q43080792 | 12-O-tetradecanoylphorbol-1, 3-acetate induces the negative regulation of protein kinase B by protein kinase Calpha during gastric cancer cell apoptosis. |
| Q39372532 | A dynamic network model of mTOR signaling reveals TSC-independent mTORC2 regulation |
| Q22001538 | A phosphoinositide 3-kinase/phospholipase Cgamma1 pathway regulates fibroblast growth factor-induced capillary tube formation |
| Q47652919 | Calcium signalling links MYC to NUAK1. |
| Q42826775 | Carboxy-terminal modulator protein induces Akt phosphorylation and activation, thereby enhancing antiapoptotic, glycogen synthetic, and glucose uptake pathways |
| Q37313698 | Combination of enzastaurin and pemetrexed inhibits cell growth and induces apoptosis of chemoresistant ovarian cancer cells regulating extracellular signal-regulated kinase 1/2 phosphorylation |
| Q21133610 | Combined RNAi-mediated suppression of Rictor and EGFR resulted in complete tumor regression in an orthotopic glioblastoma tumor model |
| Q37363611 | Conformational changes in Akt1 activation probed by amide hydrogen/deuterium exchange and nano-electrospray ionization mass spectrometry |
| Q40177635 | Critical role for classical PKC in activating Akt by phospholipase A2-modified LDL in monocytic cells |
| Q37265027 | Cross talk between the Akt and p38α pathways in macrophages downstream of Toll-like receptor signaling |
| Q52767194 | Decorin, a novel player in the insulin-like growth factor system. |
| Q34035413 | Differential and conditional activation of PKC-isoforms dictates cardiac adaptation during physiological to pathological hypertrophy. |
| Q49911674 | Dopaminergic neurotoxins induce cell death by attenuating NF-κB-mediated regulation of TRPC1 expression and autophagy |
| Q36822438 | Downstream intracellular effectors of epidermal growth factor receptor as targets for anticancer therapy |
| Q37011538 | Effect of simvastatin on glioma cell proliferation, migration, and apoptosis |
| Q35088190 | Elevated levels of cholesterol-rich lipid rafts in cancer cells are correlated with apoptosis sensitivity induced by cholesterol-depleting agents |
| Q36614997 | Elevated phosphorylation and activation of PDK-1/AKT pathway in human breast cancer |
| Q36605522 | Erlotinib resistance in lung cancer: current progress and future perspectives |
| Q39525805 | HDAC inhibitors potentiate the apoptotic effect of enzastaurin in lymphoma cells. |
| Q34956692 | High Id1 expression, a generally negative prognostic factor, paradoxically predicts a favorable prognosis for adjuvant paclitaxel plus cisplatin therapy in surgically treated lung cancer patients |
| Q36775718 | Hydrophobic motif site-phosphorylated protein kinase CβII between mTORC2 and Akt regulates high glucose-induced mesangial cell hypertrophy |
| Q34132583 | IGF-I activation of the AKT pathway is impaired in visceral but not subcutaneous preadipocytes from obese subjects |
| Q28771765 | Identification of Akt interaction protein PHF20/TZP that transcriptionally regulates p53 |
| Q33806065 | Low-level laser therapy: a useful technique for enhancing the proliferation of various cultured cells |
| Q37451135 | Mechanisms of resistance to EGFR inhibitors in head and neck cancer |
| Q37614590 | Novel agents for the treatment of adenocarcinoma of the pancreas |
| Q40445871 | Novel small molecule inhibitors of 3-phosphoinositide-dependent kinase-1. |
| Q37339512 | Ouabain stimulates protein kinase B (Akt) phosphorylation in opossum kidney proximal tubule cells through an ERK-dependent pathway |
| Q35121785 | Overexpressed PKCδ downregulates the expression of PKCα in B16F10 melanoma: induction of apoptosis by PKCδ via ceramide generation |
| Q33341346 | PDK2: the missing piece in the receptor tyrosine kinase signaling pathway puzzle |
| Q39793002 | PKC-alpha inhibitor MT477 slows tumor growth with minimal toxicity in in vivo model of non-Ras-mutated cancer via induction of apoptosis |
| Q39401591 | PKCη is a negative regulator of AKT inhibiting the IGF-I induced proliferation. |
| Q34440062 | Paeoniflorin attenuates lipopolysaccharide-induced permeability of endothelial cells: involvements of F-actin expression and phosphorylations of PI3K/Akt and PKC. |
| Q39630626 | Phosphatase PRL-3 Is a Direct Regulatory Target of TGFβ in Colon Cancer Metastasis |
| Q34219832 | Poor maternal nutrition inhibits muscle development in ovine offspring |
| Q38842875 | Protein Kinase C Isoforms Differentially Regulate Hypoxia-Inducible Factor-1α Accumulation in Cancer Cells |
| Q37421994 | Protein kinase C alpha-dependent signaling mediates endometrial cancer cell growth and tumorigenesis |
| Q28818259 | Protein kinase C isoforms: Multi-functional regulators of cell life and death |
| Q35208584 | Protein kinase C-beta gene variants, pathway activation, and enzastaurin activity in lung cancer |
| Q37676057 | Protein kinase Cdelta regulates endothelial nitric oxide synthase expression via Akt activation and nitric oxide generation |
| Q38223668 | QTc prolongation induced by targeted biotherapies used in clinical practice and under investigation: a comprehensive review. |
| Q34182228 | Receptor-specific mechanisms regulate phosphorylation of AKT at Ser473: role of RICTOR in β1 integrin-mediated cell survival. |
| Q24646815 | Regulation of Akt(ser473) phosphorylation by choline kinase in breast carcinoma cells |
| Q34806539 | Retracted: Functional Role of mTORC2 versus Integrin-Linked Kinase in Mediating Ser473-Akt Phosphorylation in PTEN-Negative Prostate and Breast Cancer Cell Lines |
| Q39929967 | Syndecan-4 regulates subcellular localization of mTOR Complex2 and Akt activation in a PKCalpha-dependent manner in endothelial cells |
| Q34144420 | TCR-induced Akt serine 473 phosphorylation is regulated by protein kinase C-alpha |
| Q54977891 | TIS21/BTG2 inhibits breast cancer growth and progression by differential regulation of mTORc1 and mTORc2-AKT1-NFAT1-PHLPP2 signaling axis. |
| Q39760304 | Targeting PKC-β II and PKB Connection: Design of Dual Inhibitors |
| Q38135123 | Targeting angiogenesis and the tumor microenvironment |
| Q52579980 | Targeting the protein kinase C family: are we there yet? |
| Q36313193 | The Akt/PKB pathway: molecular target for cancer drug discovery |
| Q54355360 | The anti-angiogenic activity of rPAI-1(23) inhibits fibroblast growth factor-2 functions. |
| Q39984715 | The heat shock protein antagonist 17-AAG potentiates the activity of enzastaurin against malignant human glioma cells |
| Q39986126 | The oral protein-kinase C beta inhibitor enzastaurin (LY317615) suppresses signalling through the AKT pathway, inhibits proliferation and induces apoptosis in multiple myeloma cell lines. |
| Q36274952 | The survival kinases Akt and Pim as potential pharmacological targets |
| Q36880063 | Vitamin E and mast cells |
| Q42809294 | mTOR.RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes |
| Q45190442 | pH-dependent domain formation in phosphatidylinositol polyphosphate/phosphatidylcholine mixed vesicles |
Search more.